Asset Turnover: The amount of sales or revenues generated per dollar of assets. The Asset Turnover ratio is an indicator of the efficiency with which a company is deploying its assets. Calculated as: Total Revenues / Total Assets
Clarus Therapeutics Holdings, Inc. (CRXTQ) had Asset Turnover of 0.27 for the most recently reported fiscal year, ending 2021-12-31.
| Income Statement Financials | |
$13.96M |
|
$-40.62M |
|
$2.72M |
|
$11.24M |
|
$53.69M |
|
$-39.73M |
|
$-0.89M |
|
$-40.62M |
|
$-40.62M |
|
$-40.62M |
|
$-40.62M |
|
$-40.62M |
|
$-40.62M |
|
$-39.73M |
|
$-39.71M |
|
7.03M |
|
7.03M |
|
$-5.72 |
|
$-5.72 |
|
| Balance Sheet Financials | |
$51.64M |
|
$0.07M |
|
$0.07M |
|
$51.71M |
|
$66.06M |
|
-- |
|
$1.57M |
|
$67.63M |
|
$-15.92M |
|
$-15.92M |
|
$-15.92M |
|
24.03M |
|
| Cash Flow Statement Financials | |
$-43.79M |
|
$-0.03M |
|
$62.99M |
|
$7.23M |
|
$26.41M |
|
$19.18M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
-- |
|
-2.66 |
|
80.51% |
|
-284.67% |
|
-284.67% |
|
-284.50% |
|
-291.02% |
|
-291.02% |
|
$-43.81M |
|
-- |
|
-- |
|
-- |
|
|
Asset Turnover |
0.27 |
0.19 |
|
2.20 |
|
165.83 |
|
255.15% |
|
255.15% |
|
-78.55% |
|
255.15% |
|
$-0.66 |
|
$-6.23 |
|
$-6.23 |
|